MarketBeat Instant News Alerts 2 hours agoSpartan Delta (TSE:SDE) PT Set at C$17.00 by Royal Bank Of CanadaMarketBeatRoyal Bank Of Canada set a C$17.00 price objective on shares of Spartan Delta and gave the company an "outperform" rating in a report on Wednesday.TSE:SDERead Spartan Delta (TSE:SDE) PT Set at C$17.00 by Royal Bank Of Canada2 hours agoVentum Financial Forecasts Strong Price Appreciation for Silver X Mining (CVE:AGX) StockMarketBeatVentum Financial boosted their price objective on Silver X Mining from C$1.60 to C$2.50 in a research note on Wednesday.CVE:AGXRead Ventum Financial Forecasts Strong Price Appreciation for Silver X Mining (CVE:AGX) Stock2 hours agoEro Copper (TSE:ERO) Price Target Raised to C$56.00MarketBeatCanadian Imperial Bank of Commerce upped their price target on shares of Ero Copper from C$52.00 to C$56.00 in a research report on Wednesday.TSE:ERORead Ero Copper (TSE:ERO) Price Target Raised to C$56.002 hours agoEndeavour Silver (TSE:EDR) Downgraded to "Neutral" Rating by Canadian Imperial Bank of CommerceMarketBeatCanadian Imperial Bank of Commerce downgraded Endeavour Silver from an "outperformer" rating to a "neutral" rating and decreased their price objective for the company from C$25.00 to C$20.00 in a report on Wednesday.TSE:EDRRead Endeavour Silver (TSE:EDR) Downgraded to "Neutral" Rating by Canadian Imperial Bank of Commerce2 hours agoCanadian Pacific Kansas City (TSE:CP) Given a C$140.00 Price Target at National Bank FinancialMarketBeatNational Bank Financial set a C$140.00 price objective on Canadian Pacific Kansas City and gave the stock an "outperform" rating in a research report on Wednesday.TSE:CPRead Canadian Pacific Kansas City (TSE:CP) Given a C$140.00 Price Target at National Bank Financial2 hours agoNational Bank Financial Issues Pessimistic Forecast for Canadian National Railway (TSE:CNR) Stock PriceMarketBeatNational Bank Financial dropped their target price on Canadian National Railway from C$192.00 to C$190.00 and set a "sector perform" rating on the stock in a research report on Wednesday.TSE:CNRRead National Bank Financial Issues Pessimistic Forecast for Canadian National Railway (TSE:CNR) Stock Price Trending News1Equities Analysts Issue Forecasts for Intel FY2027 Earnings2Boeing (NYSE:BA) Shares Down 1.6% Following Analyst Downgrade3Intuit (NASDAQ:INTU) Shares Down 4.5% - What's Next?4Jersey Mike's (NYSE:JMKE) Stock Price Down 4.2% - Here's Why5Intel (NASDAQ:INTC) Stock Price Up 1.7% - Here's What Happened6State Street Corp Sells 5,177,454 Shares of Verizon Communications Inc. $VZ7Canadian National Railway Eyes Mexico Growth With Union Pacific Deal8State Street Corp Raises Stock Holdings in Intel Corporation $INTC All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoabrdn Asia-Pacific Income Fund (NYSEAMERICAN:FAX) Reaches New 1-Year Low - Here's WhyMarketBeatNYSEAMERICAN:FAXRead abrdn Asia-Pacific Income Fund (NYSEAMERICAN:FAX) Reaches New 1-Year Low - Here's Why2 hours agoSentinelOne (NYSE:S) Reaches New 52-Week High - Here's WhyMarketBeatNYSE:SRead SentinelOne (NYSE:S) Reaches New 52-Week High - Here's Why2 hours agoPrime Medicine (NASDAQ:PRME) Stock Price Down 7.5% - Should You Sell?MarketBeatNASDAQ:PRMERead Prime Medicine (NASDAQ:PRME) Stock Price Down 7.5% - Should You Sell?2 hours agoAclaris Therapeutics (NASDAQ:ACRS) Shares Down 8.1% - Time to Sell?MarketBeatNASDAQ:ACRSRead Aclaris Therapeutics (NASDAQ:ACRS) Shares Down 8.1% - Time to Sell?2 hours agoVor Biopharma (NASDAQ:VOR) Shares Down 8.2% - Should You Sell?MarketBeatNASDAQ:VORRead Vor Biopharma (NASDAQ:VOR) Shares Down 8.2% - Should You Sell?2 hours agoNeurogene (NASDAQ:NGNE) Trading Down 8.3% - Here's WhyMarketBeatNASDAQ:NGNERead Neurogene (NASDAQ:NGNE) Trading Down 8.3% - Here's Why2 hours agoAPA (NASDAQ:APA) Trading 3.8% Higher - Time to Buy?MarketBeatNASDAQ:APARead APA (NASDAQ:APA) Trading 3.8% Higher - Time to Buy?2 hours agoVia Transportation (NYSE:VIA) Trading Up 4.2% - Here's What HappenedMarketBeatNYSE:VIARead Via Transportation (NYSE:VIA) Trading Up 4.2% - Here's What Happened2 hours agoON (NYSE:ONON) Trading Up 4.3% - What's Next?MarketBeatNYSE:ONONRead ON (NYSE:ONON) Trading Up 4.3% - What's Next?2 hours agoMitek Systems (NASDAQ:MITK) Trading Up 4.5% - Here's WhyMarketBeatNASDAQ:MITKRead Mitek Systems (NASDAQ:MITK) Trading Up 4.5% - Here's Why2 hours agoACM Research (NASDAQ:ACMR) Shares Up 4.8% - What's Next?MarketBeatNASDAQ:ACMRRead ACM Research (NASDAQ:ACMR) Shares Up 4.8% - What's Next?2 hours agoReformation (NYSE:REF) Reaches New 52-Week Low - Should You Sell?MarketBeatNYSE:REFRead Reformation (NYSE:REF) Reaches New 52-Week Low - Should You Sell?2 hours agoMidCap Financial Investment (NASDAQ:MFIC) Reaches New 12-Month Low - Here's What HappenedMarketBeatNASDAQ:MFICRead MidCap Financial Investment (NASDAQ:MFIC) Reaches New 12-Month Low - Here's What Happened2 hours agoAvnet (NASDAQ:AVT) Sets New 52-Week High - Should You Buy?MarketBeatNASDAQ:AVTRead Avnet (NASDAQ:AVT) Sets New 52-Week High - Should You Buy?2 hours agoSarepta Therapeutics (NASDAQ:SRPT) Stock Price Down 7.1% - Time to Sell?MarketBeatNASDAQ:SRPTRead Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Down 7.1% - Time to Sell?2 hours agoOlema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.1% - Time to Sell?MarketBeatNASDAQ:OLMARead Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.1% - Time to Sell?2 hours agoBlossomHill Therapeutics (NASDAQ:BLSM) Trading Down 7.2% - Here's What HappenedMarketBeatNASDAQ:BLSMRead BlossomHill Therapeutics (NASDAQ:BLSM) Trading Down 7.2% - Here's What Happened2 hours agoSana Biotechnology (NASDAQ:SANA) Shares Down 7.2% - Should You Sell?MarketBeatNASDAQ:SANARead Sana Biotechnology (NASDAQ:SANA) Shares Down 7.2% - Should You Sell?2 hours agoEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 7.2% - Should You Sell?MarketBeatNASDAQ:EWTXRead Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 7.2% - Should You Sell?2 hours agoOruka Therapeutics (NASDAQ:ORKA) Shares Down 7.4% - Here's WhyMarketBeatNASDAQ:ORKARead Oruka Therapeutics (NASDAQ:ORKA) Shares Down 7.4% - Here's Why2 hours agoAura Minerals (NASDAQ:AUGO) Stock Price Down 7.4% - What's Next?MarketBeatNASDAQ:AUGORead Aura Minerals (NASDAQ:AUGO) Stock Price Down 7.4% - What's Next?2 hours agoNuvectis Pharma (NASDAQ:NVCT) Shares Down 7.5% - Should You Sell?MarketBeatNASDAQ:NVCTRead Nuvectis Pharma (NASDAQ:NVCT) Shares Down 7.5% - Should You Sell?2 hours agoCrescent Biopharma (NASDAQ:CBIO) Shares Down 8% - Here's WhyMarketBeatNASDAQ:CBIORead Crescent Biopharma (NASDAQ:CBIO) Shares Down 8% - Here's Why2 hours agoAlto Neuroscience (NYSE:ANRO) Stock Price Down 8.3% - Time to Sell?MarketBeatNYSE:ANRORead Alto Neuroscience (NYSE:ANRO) Stock Price Down 8.3% - Time to Sell? Featured Articles and OffersNVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In ItBy Bridget Bennett | September 20, 2026Ready to give options a try? Your first trade (Ticker included) -INSIDEFrom Base Camp Trading (Ad)3 Luxury Consumer Brands to Watch in a Beaten-Down SectorBy Nathan Reiff | September 16, 2026Aeluma’s Selloff Could Be Setting Up Its Next Big MoveBy Thomas Hughes | September 17, 2026IonQ and NVIDIA Just Cracked a Major Quantum Computing BottleneckBy Jeffrey Neal Johnson | September 17, 2026Shocking new footage just releasedFrom Digest Publishing (Ad)The Fed’s Rate Hike Could Backfire If Oil Prices CollapseBy Thomas Hughes | September 17, 2026Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?By Thomas Hughes | September 21, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 197 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
